These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 9177438

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival.
    Gupta P, Niehans GA, LeRoy SC, Gupta K, Morrison VA, Schultz C, Knapp DJ, Kratzke RA.
    Leukemia; 1999 Jan; 13(1):44-53. PubMed ID: 10049059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Increased apoptosis in mononucleated cells but not in CD34+ cells in blastic forms of myelodysplastic syndromes.
    Berger G, Hunault-Berger M, Rachieru P, Fontenay-Roupie M, Baranger L, Ifrah N, Zandecki M.
    Hematol J; 2001 Jan; 2(2):87-96. PubMed ID: 11424000
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K, Ohshima K, Suzumiya J, Kawasaki C, Kikuchi M.
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F, Krauth MT, Vales A, Böhm A, Agis H, Sonneck K, Aichberger KJ, Mayerhofer M, Simonitsch-Klupp I, Müllauer L, Sperr WR, Valent P.
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K, Kohno T, Chen YX, Tsushima H, Mori H, Nakamura H, Jinnai I, Matsuo T, Kuriyama K, Tomonaga M, Bennett JM.
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [Abstract] [Full Text] [Related]

  • 19. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway.
    Dror Y, Freedman MH.
    Blood; 2001 May 15; 97(10):3011-6. PubMed ID: 11342425
    [Abstract] [Full Text] [Related]

  • 20. Role of cytokines in leukemic type growth of myelodysplastic CD34+ cells.
    Sawada K, Ieko M, Notoya A, Tarumi T, Koizumi K, Kitayama S, Nishio H, Fukada Y, Yasukouchi T, Yamaguchi M, Katoh S, Koike T.
    Blood; 1996 Jul 01; 88(1):319-27. PubMed ID: 8704190
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.